Prelude Therapeutics OverviewPrelude Therapeutics Net Income
Profitability analysis for PRLD.
Quarterly Net Income
-$10.38M
↑ 67.63% YoY
As of Mar 2026
Annual Net Income (TTM)
-$77.80M
↑ 39.14% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...